A carregar...
Current management of RET rearranged non-small cell lung cancer
The identification of oncogenic drivers, and the subsequent development of targeted therapies established biomarker-based care for metastatic non-small cell lung cancer (NSCLC). Biomarker testing is standard of care in NSCLC patients with adenocarcinoma because multiple targeted therapies are availa...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385825/ https://ncbi.nlm.nih.gov/pubmed/32782485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920928634 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|